Physician profile
Michael Murray
NPI 1467484147
$32,702.71
in general payments reported to CMS, 2019-2025
25 companies · $487 in 2025
The $487 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $18K · 2021: $8,759 · 2022: $273 · 2023: $4,195 · 2024: $403 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,574 · Food and Beverage: $2,411 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,573.70 |
| Food and Beverage | $2,411.44 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $24,267.07 | 2019-2023 | |
| Procept Biorobotics Corporation | $2,139.77 | 2023-2025 | Aquabeam Robotic System |
| Bayer Healthcare Pharmaceuticals INC. | $1,974.69 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $1,786.52 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $590.02 | 2020-2025 | Erleada, Akeega |
| Progenics Pharmaceuticals, INC. | $287.65 | 2023-2025 | Pylarify |
| Astellas Pharma US INC | $271.80 | 2019-2024 | Myrbetriq, Veozah |
| Healthtronics Stone Solutions, LLC | $237.72 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $174.22 | 2019-2025 | Erleada, Akeega |
| Medtronic, INC. | $163.39 | 2023 | Interstim |
| Axonics, INC. | $122.39 | 2021-2023 | Axonics, Bulkamid |
| Ferring Pharmaceuticals INC. | $122.04 | 2024 | Adstiladrin |
| Pfizer INC. | $93.41 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $70.31 | 2020-2024 | |
| Sumitomo Pharma America, INC. | $65.22 | 2023-2025 | Orgovyx |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $65.04 | 2022 | |
| Abbvie INC. | $53.91 | 2022 | |
| Urogen Pharma, INC. | $43.87 | 2021-2023 | Jelmyto |
| Laborie Medical Technologies Corp. | $41.79 | 2021 | |
| Telix Pharmaceuticals | $31.42 | 2024 | Illuccix |
| Angiodynamics, INC. | $27.54 | 2023 | Nanoknife |
| Immunitybio, INC. | $23.50 | 2024 | |
| Myovant Sciences INC. | $17.11 | 2022 | |
| 180 Medical, INC. | $16.68 | 2019 | |
| Becton, Dickinson and Company | $15.63 | 2024 | Bard Urinary Drainage Bag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.